Group format psychedelic-assisted therapy interventions: Observations and impressions from the HOPE trial

被引:5
|
作者
Lewis, Benjamin R. [1 ,2 ]
Byrne, Kevin [1 ]
Hendrick, John [1 ]
Garland, Eric L. [1 ]
Thielking, Paul [1 ]
Beck, Anna [1 ]
机构
[1] Univ Utah, Salt Lake City, UT USA
[2] Huntsman Mental Hlth Inst, 501 Chipeta Way, Salt Lake City, UT 84108 USA
来源
JOURNAL OF PSYCHEDELIC STUDIES | 2023年 / 7卷 / 01期
关键词
psilocybin; psychedelic therapy; cancer; group therapy; LIFE-THREATENING CANCER; PSILOCYBIN TREATMENT; ANXIETY; DEPRESSION;
D O I
10.1556/2054.2022.00222
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Psilocybin-assisted psychotherapy has demonstrated significant promise as a treatment for depression, anxiety, and existential distress associated with serious medical illness and has generally been employed on an individual basis, which presents challenges for scaling and resource availability. There are also compelling theoretical reasons to suggest that group-based formats-if utilized in a thoughtful fashion-might offer unique or enhanced therapeutic benefits for certain conditions or populations. The HOPE trial is an IRB-approved open-label feasibility and safety pilot study of psi-locybin enhanced group therapy in patients with a DSM-5 depressive disorder associated with a cancer diagnosis completed at the Huntsman Cancer Institute (HCI) in Salt Lake City, Utah (HOPE: A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients with Cancer). We report here quali-tative survey-based data, impressions, and suggestions for group-based psychedelic-assisted therapy interventions based on our observations to inform future studies. Methods: Patients with a DSM-5 depressive disorder with an underlying cancer diagnosis were recruited from HCI by referral from oncology providers, palliative care, and social work. Following screening and consenting, 4-6 partici-pants per cohort (with three total cohorts) were enrolled in a protocol involving 3 120 min group preparatory sessions, a single high-dose (25 mg) group psilocybin session, and 3 subsequent group integration sessions. Primary clinical outcomes are still in process of data collection and analysis. Qualitative data was gathered from patient written reports and a survey administered at 2 weeks post intervention. Qualitative reports were also gathered from the therapist team at a post-study group process session. Findings: We report here results from a qualitative survey of participant experiences with group format study design, as well as impressions and guidelines for group format and group psychotherapeutic process to inform other studies pursuing group-based interventions in psychedelic therapy. Suggestions are provided for protocol design, screening processes, space considerations, therapist team structure, group process, music, timeline, as well as potential issues and challenges.
引用
收藏
页码:1 / 11
页数:11
相关论文
共 50 条
  • [21] THE PATH OPENS: PSYCHEDELIC-ASSISTED THERAPY IN THE AUSTRALIAN CONTEXT
    Starke, J.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2023, 57 (01): : 84 - 84
  • [22] Harnessing Pharmacogenomics in Clinical Research on Psychedelic-Assisted Therapy
    Halman, Andreas
    Conyers, Rachel
    Moore, Claire
    Khatri, Dhrita
    Sarris, Jerome
    Perkins, Daniel
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2025, 117 (01) : 106 - 115
  • [23] Psychedelic-assisted therapy: a new approach to treating depression
    Rands, Peter
    NATURE NEUROSCIENCE, 2021, 24 (01) : B29 - B29
  • [24] From Isolation to Social (and Psychedelic) Integration: A Sociology of Collective Effervescence and Therapeutic Community in Psychedelic-Assisted Therapy
    Rose, Jarrett Robert
    SOCIOLOGY OF HEALTH & ILLNESS, 2025, 47 (01)
  • [25] Psychedelic-Assisted Psychotherapy-A Systematic Review of Associated Psychological Interventions
    Cavarra, Mauro
    Falzone, Alessandra
    Ramaekers, Johannes G.
    Kuypers, Kim P. C.
    Mento, Carmela
    FRONTIERS IN PSYCHOLOGY, 2022, 13
  • [26] Psychedelic-Assisted Therapies and Pediatric Palliative Care: New Tools for Hope and Healing
    Waldman, Elisha
    Adrian, Chris
    Spence, Dingle
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2023, 65 (03) : E261 - E262
  • [27] Research and Implementation of Psychedelic-Assisted Therapy in the Veterans Health Administration
    Wolfgang, Aaron S.
    Mcclair, Vetisha L.
    Schnurr, Paula P.
    Holtzheimer, Paul E.
    Woolley, Josh D.
    Stauffer, Christopher S.
    Wolf, Cameron
    States, Leith J.
    Benedek, David M.
    Capaldi, Vincent F.
    Bradley, John
    Fuller, Matthew A.
    Smyth, Miriam J.
    Hermes, Eric D. A.
    Tenhula, Wendy
    Wiechers, Ilse R.
    AMERICAN JOURNAL OF PSYCHIATRY, 2025, 182 (01): : 17 - 20
  • [28] Psychedelic-assisted Therapy as a Promising Treatment for Irritable Bowel Syndrome
    Mauney, Erin
    King, Franklin
    Burton-Murray, Helen
    Kuo, Braden
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2025, 59 (05) : 385 - 392
  • [29] Ethical considerations for psychedelic-assisted therapy in military clinical settings
    Hoener, Scott
    Wolfgang, Aaron
    Nissan, David
    Howe, Edmund
    JOURNAL OF MEDICAL ETHICS, 2024, 50 (04) : 258 - 262
  • [30] PSYCHEDELIC-ASSISTED THERAPY: KNOWLEDGE AND ATTITUDES OF MENTAL HEALTH PROFESSIONALS
    Adam, E.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2024, 58 : 104 - 104